FR4135M - - Google Patents

Info

Publication number
FR4135M
FR4135M FR2411A FR2411A FR4135M FR 4135 M FR4135 M FR 4135M FR 2411 A FR2411 A FR 2411A FR 2411 A FR2411 A FR 2411A FR 4135 M FR4135 M FR 4135M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR2411A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR2411A priority Critical patent/FR4135M/fr
Application granted granted Critical
Publication of FR4135M publication Critical patent/FR4135M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
FR2411A 1965-01-19 1965-01-19 Expired FR4135M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR2411A FR4135M (fr) 1965-01-19 1965-01-19

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR2411A FR4135M (fr) 1965-01-19 1965-01-19

Publications (1)

Publication Number Publication Date
FR4135M true FR4135M (fr) 1966-05-02

Family

ID=85874020

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2411A Expired FR4135M (fr) 1965-01-19 1965-01-19

Country Status (1)

Country Link
FR (1) FR4135M (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100037A2 (fr) * 1982-07-29 1984-02-08 Merckle GmbH Médicament pour le traitement des troubles du sommeil
EP0150721A2 (fr) * 1984-01-25 1985-08-07 Firma Paliz, Ziegler Médicament
EP0227356A2 (fr) * 1985-12-04 1987-07-01 CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. Utilisation de dépogène pour le traitement de la circulation réduite du sang

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100037A2 (fr) * 1982-07-29 1984-02-08 Merckle GmbH Médicament pour le traitement des troubles du sommeil
EP0100037A3 (en) * 1982-07-29 1985-01-09 Merckle Gmbh Medicament for treating sleep disorders
EP0150721A2 (fr) * 1984-01-25 1985-08-07 Firma Paliz, Ziegler Médicament
EP0150721A3 (fr) * 1984-01-25 1987-06-16 Firma Paliz, Ziegler Médicament
EP0227356A2 (fr) * 1985-12-04 1987-07-01 CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. Utilisation de dépogène pour le traitement de la circulation réduite du sang
EP0227356A3 (en) * 1985-12-04 1989-12-13 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. The use of depogen in the treatment of restricted blood circulation

Similar Documents

Publication Publication Date Title
BE674763A (fr)
FI46927B (fr)
FR4135M (fr)
JPS4418453Y1 (fr)
JPS412189Y1 (fr)
JPS4528244Y1 (fr)
JPS4112377Y1 (fr)
JPS4421198Y1 (fr)
JPS44103Y1 (fr)
JPS433567Y1 (fr)
JPS4321573Y1 (fr)
JPS425282Y1 (fr)
JPS4125350Y1 (fr)
JPS468645Y1 (fr)
BE675423A (fr)
NL6617661A (fr)
BE677446A (fr)
BE675734A (fr)
BE675717A (fr)
BE675701A (fr)
BE665788A (fr)
BE675689A (fr)
BE675592A (fr)
BE675472A (fr)
BE674906A (fr)